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investigating disease, homeostasis of articular joint, and tissue
engineering of functional superficial zone of articular cartilage.
Synthetic triterpenoids (TPs) are potent multifunctional
molecules. However, their effects in various types of cells are
still unclear. TP-151 and its derivative, TP-235 are synthetic
triterpenoids and reported to possess capacities to modulate
transforming growth factor-β (TGF-β)/Smad signaling in several
types of cells.
We hypothesized that synthetic triterpenoids could regulate SZP
synthesis in articular chondrocytes because TGF-β is known to
possess a capacity to up-regulate SZP synthesis. The aim of this
study is to investigate whether synthetic triterpenoids regulate
SZP synthesis in articular chondrocytes.
Methods: Bovine calf stifle joints were used in this study. The
superficial zone of articular cartilage was harvested using a
dermatome. The cartilage slices were digested with 0.2% colla-
genase P in culture medium. Isolated chondrocytes were plated
in monolayer and cultured in the serum-free chemically defined
media. Various concentrations of synthetic triterpenoids were
added into the cell culture. We used four TPs, TP-151, TP-155,
TP-235, and TP-319 in this study.
As most of SZP is secreted into the culture medium, supernatants
were harvested as samples and the SZP synthesis was analyzed
by SDS-PAGE and Western blotting using a monoclonal antibody
S6.79. SZP accumulation into the culture medium was also
quantified by ELISA using purified SZP as standard.
Results: TGF-β1: Recombinant human TGF-β1 up-regulated
SZP synthesis in a dose-dependent manner (0.4-120 pM).
TPs at higher concentrations: All four TPs down-regulated SZP
synthesis in a dose-dependent manner at higher concentrations
(100-1000 nM). Concurrent treatment with TGF-β1 (4 pM) also
demonstrated the same trend.
TPs at lower concentrations: TP-151 and TP-155 up-regulated
SZP synthesis at lower concentrations (0.01-1 nM). TP-235 and
TP-319 exhibited no obvious effects in this range.
Conclusions: TP-151 and TP-235 were reported to increase
the expression of TGF-β-dependent genes and synergize with
TGF-β in this regard at nanomolar concentrations in cells of
epithelial and hematopoietic origin. Moreover, they are reported
to prolong the activation of Smad 2 induced by TGF-β and
enhance the ability of Smad 3. Other investigators reported that
TP-151 induced TGF-β1 production and Smad 2 expression in
intraepithelial lymphocytes.
However, on the other hand, TP-151 (300 nM) was reported to
antagonize Smad-dependent transcription of CAGA12-luciferase
in chondrocytic cells. Therefore the effects of TPs on TGF-
β/Smad signaling is still controversial. Synthetic triterpenoids
may have tissue/cell-specific effects on the Smad pathway.
Our results demonstrated biphasic effects of TP-151 and TP-
155. The down-regulation of TP-151 at higher concentrations is
compatible with the report that 300 nM of TP-151 antagonized
Smad-dependent transcription of CAGA12-luciferase in chondro-
cytic cells. Our results suggested that sub-nanomolar concentra-
tions were optimal for articular chondrocytes. The effects of TPs
on the other zones of articular cartilage (middle zone and deep
zone) are also important targets to investigate.
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Purpose: The clinical outcome in osteochondral allografting is
limited due to the immunological incompatibility of the osseous
portion. A means to improve the clinical outcome consists in
the pretreatment of allografts to achieve a devitalized osseous
portion while maintaining the function of cartilage. Photodynamic
therapy (PDT) is based on the preferential accumulation of a
photosensitizing drug in a target tissue and its activation by light.
Formation of cytotoxic products leads to selective destruction of
cells containing the photosensitizer. Cell culture experiments with
cartilage and bone cells revealed that chondrocytes remained
viable and functional after 5-aminolaevulinic acid (5-ALA) based
PDT, whereas primary osteoblast-like cells showed a strong
decrease in function and survival. This lead to the hypothesis,
that 5-ALA-PDT can be applied to devitalize the osseous portion
of an osteochondral graft selectively, while maintaining cartilage
function. The aim of this study was to expand the cell culture
experiments to an ex vivo tissue culture model.
Methods: Cylindrical osteochondral grafts (5x10 mm) were har-
vested from porcine humeral heads. After incubation for 4h at
37°C in 1mM ALA the grafts were illuminated with 5, 10 and
20J/cm2. Control grafts were fixed immediately after harvest ("di-
rect fixation"), incubated in 1mM ALA ("ala-dark") or illuminated
with 20 J/cm2 in the absence of incubation with 5-ALA ("light
alone"). After treatment, the grafts were cultured at 37°C for 4h.
Subsequently the grafts were either fixed in paraformaldehyde
or stored for further 16h at 4°C before fixation. The function
of the cells was assessed by in situ hybridization for mR-
NAs encoding collagen type I (colα1(I); osteoblasts) and type
II (colα1(II);chondrocytes).
Results: The surface of trabeculae bone covered with os-
teoblasts positive for mRNA encoding colα1(I) was 0.52±0.34
("ala-dark"), 0.57±0.13 (5J/cm2), 0.47±0.28 (10J/cm2),
0.50±0.32 (20J/cm2) 4h post PDT and 0.29±0.12, 0.30±0.21,
0.25±0.16 and 0.26±0.13 respectively 20h post PDT
(mean±SD, % of total trabecular surface, relative to "di-
rect fixation"). The area covered with chondrocytes posi-
tive for mRNA encoding colα1(II) was 0.93±0.08, 0.96±0.03,
0.67±0.09, 0.70±0.15 respectively 4h post PDT and 0.94±0.08,
0.76±0.12, 0.61±0.17 and 0.38±0.17 respectively 20h post PDT
(mean±SD, % of total cartilage, relative to "direct fixation"). The
loss of colα1(I) expression in osteoblasts 20h post PDT in the
groups "ala-dark", 5,10,20 J/cm2 compared to the control "direct
fixation" was statistically significant. The loss of colα1(II) expres-
sion in chondrocytes was statistically significant for the groups
10 and 20J/cm2 compared to the control "direct fixation" 4h and
20h post PDT.
Conclusions: Bone cells become non functional during the 24h
experimental protocol. There is no additional effect of 5-ALA-
PDT on bone cells, may be due to the spontaneous cell death
occurring in these cells in the culture or either 5-ALA could not
sufficiently diffuse through the osseous tissue, the light pene-
tration was not sufficient, or a combination of both. 5-ALA-PDT
caused an unexpected loss of functional chondrocytes within
the cartilage maybe due to an increased sensitivity caused by
the characteristics of this experimental setup. Chondrocytes re-
mained functional in the control group for tissue culture whereas
osteoblasts were sensitive to the applied tissue culture con-
ditions. The aim of the study to obtain a devitalized osseous
portion but functional cartilage could rather be achieved by the
applied tissue culture conditions than by 5-ALA-PDT.
